Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Barber, Louise J ^a   Rosa, Juan M Rosa ^a   Kozarewa, Iwanka ^a   Fenwick, Kerry ^a   Assiotis, Ioannis ^a   Mitsopoulos, Costas ^a   Sims, David ^a   Hakas, Jarle ^a   Zvelebil, Marketa ^a   Lord, Christopher J ^a   Ashworth, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA2 PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BRCA2 GENE; CANCER CELL CULTURE; CANCER GROWTH; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; DNA SEQUENCE; DNA STRUCTURE; EXOME; FEMALE; GENE FUNCTION; GENE LOSS; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; GENOME ANALYSIS; HAPLOTYPE MAP; HUMAN; HUMAN CELL; INDEL MUTATION; MALE; MUTATIONAL ANALYSIS; PANCREAS CANCER; PROTEIN FUNCTION; SHORT SEQUENCE REPEAT; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; CHROMOSOME MAP; COMPARATIVE GENOMIC HYBRIDIZATION; GENETICS; GENOMICS; HUMAN GENOME; METHODOLOGY; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; BRCA2 PROTEIN; CELL LINE, TUMOR; CHROMOSOME MAPPING; COMPARATIVE GENOMIC HYBRIDIZATION; GENOME, HUMAN; GENOMICS; HUMANS; PANCREATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA;

EID: 79959995341     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021639     Document Type: Article

References (69)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, et al. (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72: 1117-1130.
2. Tai YC, Domchek S, Parmigiani G, Chen S, (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99: 1811-1814.
3. Turnbull C, Hodgson S, (2005) Genetic predisposition to cancer. Clin Med 5: 491-498.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
5. Wong HH, Lemoine NR, (2009) Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol 6: 412-422.
6. Moynahan ME, Pierce AJ, Jasin M, (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol Cell 7: 263-272.
7. Moynahan ME, Chiu JW, Koller BH, Jasin M, (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4: 511-518.
8. Hoeijmakers JH, (2001) Genome maintenance mechanisms for preventing cancer. Nature 411: 366-374.
9. Lindahl T, (1993) Instability and decay of the primary structure of DNA. Nature 362: 709-715.
10. Tutt A, Bertwistle D, Valentine J, Gabriel A, Swift S, et al. (2001) Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences. EMBO J 20: 4704-4716.
11. Gudmundsdottir K, Ashworth A, (2006) The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25: 5864-5874.
12. Fogh J, Fogh JM, Orfeo T, (1977) One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59: 221-226.
13. Fogh J, Wright WC, Loveless JD, (1977) Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J Natl Cancer Inst 58: 209-214.
14. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, et al. (1996) Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56: 5360-5364.
15. Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, et al. (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451: 1111-1115.
16. Yang H, Jeffrey PD, Miller J, Kinnucan E, Sun Y, et al. (2002) BRCA2 function in DNA binding and recombination from a BRCA2-DSS1-ssDNA structure. Science 297: 1837-1848.
17. Davies OR, Pellegrini L, (2007) Interaction with the BRCA2 C terminus protects RAD51-DNA filaments from disassembly by BRC repeats. Nat Struct Mol Biol 14: 475-483.
18. Esashi F, Galkin VE, Yu X, Egelman EH, West SC, (2007) Stabilization of RAD51 nucleoprotein filaments by the C-terminal region of BRCA2. Nat Struct Mol Biol 14: 468-474.
19. Spain BH, Larson CJ, Shihabuddin LS, Gage FH, Verma IM, (1999) Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations. Proc Natl Acad Sci U S A 96: 13920-13925.
20. Yuan SS, Lee SY, Chen G, Song M, Tomlinson GE, et al. (1999) BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res 59: 3547-3551.
21. Ghadimi BM, Schrock E, Walker RL, Wangsa D, Jauho A, et al. (1999) Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 154: 525-536.
22. Kozarewa I, Ning Z, Quail MA, Sanders MJ, Berriman M, et al. (2009) Amplification-free Illumina sequencing-library preparation facilitates improved mapping and assembly of (G+C)-biased genomes. Nat Methods 6: 291-295.
23. Li H, Durbin R, (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
24. Pleasance ED, Stephens PJ, O'Meara S, McBride DJ, Meynert A, et al. (2010) A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463: 184-190.
25. Chen ZH, Zhang H, Savarese TM, (1996) Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy. Cancer Res 56: 1083-1090.
26. Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 6: 677-681.
27. Stephens PJ, McBride DJ, Lin ML, Varela I, Pleasance ED, et al. (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462: 1005-1010.
28. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
29. Yamasaki N, Miyazaki K, Nagamachi A, Koller R, Oda H, et al. (2010) Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia. Oncogene 29: 1963-1975.
30. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
31. Ye K, Schulz MH, Long Q, Apweiler R, Ning Z, (2009) Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads. Bioinformatics 25: 2865-2871.
32. Kalthoff H, Schmiegel W, Roeder C, Kasche D, Schmidt A, et al. (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8: 289-298.
33. Hsiang D, Friess H, Buchler MW, Ebert M, Butler J, et al. (1997) Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. Am J Surg 174: 242-246.
34. Bartsch D, Barth P, Bastian D, Ramaswamy A, Gerdes B, et al. (1999) Higher frequency of DPC4/Smad4 alterations in pancreatic cancer cell lines than in primary pancreatic adenocarcinomas. Cancer Lett 139: 43-49.
35. Teng DH, Perry WL 3rd, Hogan JK, Baumgard M, Bell R, et al. (1997) Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 57: 4177-4182.
36. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, et al. (2010) A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463: 191-196.
37. Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, et al. (2007) Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 67: 2298-2305.
38. Natsume W, Tanabe K, Kon S, Yoshida N, Watanabe T, et al. (2006) SMAP2, a novel ARF GTPase-activating protein, interacts with clathrin and clathrin assembly protein and functions on the AP-1-positive early endosome/trans-Golgi network. Mol Biol Cell 17: 2592-2603.
39. Ng PC, Henikoff S, (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
40. SIFT website. Available: http://sift.jcvi.org/. Accessed 2011 June 16.
41. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D, (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7: 575-576.
42. Mutation Taster website. Available: http://www.mutationtaster.org/. Accessed: 2011 June 16.
43. Huang da W, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57.
44. DAVID website. Available: http://david.abcc.ncifcrf.gov/. Accessed 2011 June 16.
45. CGC website. Available: http://www.sanger.ac.uk/genetics/CGP/Census/. Accessed 2011 June 16.
46. Koike J, Takagi A, Miwa T, Hirai M, Terada M, et al. (1999) Molecular cloning of Frizzled-10, a novel member of the Frizzled gene family. Biochem Biophys Res Commun 262: 39-43.
47. Rehn M, Pihlajaniemi T, Hofmann K, Bucher P, (1998) The frizzled motif: in how many different protein families does it occur? Trends Biochem Sci 23: 415-417.
48. Dann CE, Hsieh JC, Rattner A, Sharma D, Nathans J, et al. (2001) Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature 412: 86-90.
49. Terasaki H, Saitoh T, Shiokawa K, Katoh M, (2002) Frizzled-10, up-regulated in primary colorectal cancer, is a positive regulator of the WNT- beta-catenin- TCF signaling pathway. Int J Mol Med 9: 107-112.
50. Zeng G, Germinaro M, Micsenyi A, Monga NK, Bell A, et al. (2006) Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma. Neoplasia 8: 279-289.
51. Keino-Masu K, Masu M, Hinck L, Leonardo ED, Chan SS, et al. (1996) Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 87: 175-185.
52. Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, et al. (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395: 801-804.
53. Hilgers W, Song JJ, Haye M, Hruban RR, Kern SE, et al. (2000) Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers. Genes Chromosomes Cancer 27: 353-357.
54. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, et al. (2006) The consensus coding sequences of human breast and colorectal cancers. Science 314: 268-274.
55. Meriane M, Tcherkezian J, Webber CA, Danek EI, Triki I, et al. (2004) Phosphorylation of DCC by Fyn mediates Netrin-1 signaling in growth cone guidance. J Cell Biol 167: 687-698.
56. Clark MJ, Homer N, O'Connor BD, Chen Z, Eskin A, et al. (2010) U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line. PLoS Genet 6: e1000832.
57. Ding L, Ellis MJ, Li S, Larson DE, Chen K, et al. (2010) Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 464: 999-1005.
58. Herath NI, Boyd AW, (2010) The role of Eph receptors and ephrin ligands in colorectal cancer. Int J Cancer 126: 2003-2011.
59. Weinstock DM, Elliott B, Jasin M, (2006) A model of oncogenic rearrangements: differences between chromosomal translocation mechanisms and simple double-strand break repair. Blood 107: 777-780.
60. Campbell PJ, Stephens PJ, Pleasance ED, O'Meara S, Li H, et al. (2008) Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nat Genet 40: 722-729.
61. Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, et al. (2011) Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development. Cell 144: 27-40.
62. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
63. Yachida S, Jones S, Bozic I, Antal T, Leary R, et al. (2010) Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467: 1114-1117.
64. Ahn SM, Kim TH, Lee S, Kim D, Ghang H, et al. (2009) The first Korean genome sequence and analysis: full genome sequencing for a socio-ethnic group. Genome Res 19: 1622-1629.
65. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, et al. (2007) The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113.
66. Lord CJ, Ashworth A, (2008) Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8: 363-369.
67. Mackay A, Tamber N, Fenwick K, Iravani M, Grigoriadis A, et al. (2009) A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat 118: 481-498.
68. Natrajan R, Weigelt B, Mackay A, Geyer FC, Grigoriadis A, et al. (2010) An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res Treat 121: 575-589.
69. UCSC In Silico PCR tool website. Available: http://genome.ucsc.edu/cgi-bin/hgPcr. Accessed 2011 June 16.